Tesamorelin for visceral fat: what the research actually shows
There are two types of fat in your body, and only one of them is actually dangerous. The fat you can pinch is largely cosmetic. The fat wrapped around your organs is the kind that drives insulin resistance, raises cardiovascular risk, and quietly damages your metabolic health over time. One peptide has been specifically studied and FDA-approved to target it. It's called tesamorelin, and the clinical trials behind it are some of the most compelling data in the peptide space.
I tried retatrutide: and it wasn't just the weight loss that that surprised me
I started researching retatrutide for one reason, not weight loss, but food noise. As someone who has always had a complicated relationship with food, I needed to find out if it was real. Here's my honest experience, including the side effects I didn't expect.
What are peptides, and why is everyone suddenly on them
Peptides are showing up everywhere right now — for weight loss, injury recovery, skin health, and longevity. But most of the conversation skips straight to results without explaining what peptides actually are or how they work.
Here's what the research actually shows, why retatrutide is generating so much attention compared to existing GLP-1 medications, and what you need to understand about where regulation currently stands before the conversation moves any further.